|
|
Volumn 32, Issue 19, 2014, Pages 2114-
|
|
Reply to J. Menczer
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER ADJUVANT THERAPY;
CANCER CHEMOTHERAPY;
CANCER GRADING;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CANCER STAGING;
CANCER SURVIVAL;
DISEASE SEVERITY;
ENDOMETRIOID CARCINOMA;
FOLLOW UP;
HISTOLOGY;
HUMAN;
HYSTERECTOMY;
LETTER;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
UTERUS CANCER;
ADENOSQUAMOUS CARCINOMA;
CANCER DIAGNOSIS;
CANCER PATIENT;
CANCER SURGERY;
CANCER THERAPY;
CLEAR CELL CARCINOMA;
ENDOMETRIUM CANCER;
SARCOMA;
THERAPY DELAY;
TIME;
CARCINOMA, ENDOMETRIOID;
FEMALE;
HUMANS;
HYSTERECTOMY;
INSURANCE COVERAGE;
TIME-TO-TREATMENT;
UTERINE NEOPLASMS;
WAITING LISTS;
|
|
EID: 84905855439
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2014.55.7215 Document Type: Letter |
|
Times cited : (3)
|
|
References (2)
|
